MedTrace Logo

Bicuspid Valve Aortopathy Feasibility Study

NCT01920815 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 500

Last updated 2018-09-19

No results posted yet for this study

Summary

In order to determine the effectiveness of medical therapy options to prevent enlargement of the aorta in patients with a bicuspid aortic valve, a randomized study will be planned. This feasibility study will gather accurate data on number needed to screen, changes in medication use over time, and variance of the intended study endpoint.

Conditions

  • Bicuspid Aortic Valve

Interventions

OTHER

No interventions

Sponsors & Collaborators

  • Emory University

    collaborator OTHER

  • University of Colorado, Denver

    collaborator OTHER

  • Baylor College of Medicine

    collaborator OTHER

  • University of California, Los Angeles

    collaborator OTHER

  • Penn State University

    collaborator OTHER

  • Oregon Health and Science University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2016-06-30
Completion
2017-10-04

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01920815 on ClinicalTrials.gov